Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 23 | -919 | 256 | 433 | 269 |
| Cost of Goods | 10 | -338 | 99 | 185 | 76 |
| Gross Profit | 14 | -581 | 158 | 247 | 193 |
| Operating Expenses | 311 | -430 | 836 | 1,048 | 613 |
| Operating Income | -288 | -489 | -580 | -615 | -344 |
| Interest Expense | 82 | 453 | 20 | 129 | 189 |
| Other Income | -242 | 176 | -898 | -224 | -81 |
| Pre-tax Income | -612 | -765 | -1,498 | -968 | -614 |
| Net Income Continuous | -612 | -766 | -1,498 | -968 | -614 |
| Net Income Discontinuous | -127 | N/A | N/A | N/A | N/A |
| Net Income | $-739 | $-1,172 | $-1,498 | $-968 | $-614 |
| EPS Basic Total Ops | -59.70 | -179.10 | -179.10 | -119.40 | -59.70 |
| EPS Basic Continuous Ops | -63.34 | -77.31 | -186.15 | -130.29 | -83.86 |
| EPS Basic Discontinuous Ops | -13.15 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -59.70 | -179.10 | -179.10 | -119.40 | -59.70 |
| EPS Diluted Continuous Ops | -63.34 | -77.31 | -186.15 | -130.29 | -83.86 |
| EPS Diluted Discontinuous Ops | -13.15 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-144 | $-344 | $-504 | $-429 | $-101 |